- Corporate Officers - S
- Samuelson Doug
Insider Trading History of Samuelson Doug
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Samuelson Doug since 2023.
This trader's CIK number is 1943326.
At the time of last reporting, Samuelson Doug was the Chief Financial Officer of Kairos Pharma, Ltd.. (stock ticker symbol KAPA).
Also see all insider trading activities at Kairos Pharma, Ltd..
Note that in the past
Samuelson Doug also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Kairos Pharma, Ltd. (KAPA) by Samuelson Doug
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | KAPA | 2,500 | $3,750 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Genelux Corp (GNLX) by Samuelson Doug
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | GNLX | 0 | $0 | 1,297 | $30,777 | 0 | $0 |
Insider trading activities at 2 companies by Samuelson Doug:
1. Kairos Pharma, Ltd. (KAPA)
2. Genelux Corp (GNLX)
Table 1. Insider trading of Kairos Pharma, Ltd. (KAPA) by Samuelson Doug
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-11-22 | KAPA | Buy | 2,500 | 1.50 | 3,750 |
Table 2. Insider trading of Genelux Corp (GNLX) by Samuelson Doug
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-18 | GNLX | Sale | 1,297 | 23.73 | 30,777 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Samuelson Doug
(Chief Financial Officer of Kairos Pharma, Ltd. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.